Intravitreal MTX and ZR Regimen in Newly Diagnosed PVRL

NCT04899453 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Primary Vitreoretinal Lymphoma

Interventions

DRUG: Methotrexate
DRUG: Rituximab
DRUG: Zanubrutinib

Sponsor

Peking Union Medical College Hospital